期刊文献+

右美托咪定辅助喉罩全麻对老年全髋关节置换术术后躁动的影响 被引量:4

Influence of dexmedtomidine on emergence agitation undergoing total hip replacement surgery
下载PDF
导出
摘要 目的观察右美托咪定辅助喉罩全麻对老年全髋关节置换手术术后躁动的影响。方法选择我院2012年1月至2013年3月接受全髋骨关节置换手术患者60例,随机分为观察组和对照组,每组30例。两组均使用喉罩全麻,在手术结束前30 min观察组患者静脉泵入右美托咪定,对照组患者静脉泵入生理盐水,记录两组患者血流动力学指标变化和苏醒期躁动的发生率。结果观察组患者的血压、心率等指标很快恢复到正常水平,而对照组患者恢复较慢,拔管5 min后仍与基准水平存在差距;观察组全麻苏醒期躁动发生率为3.33%,对照组为13.33%,两组比较差异有统计学意义(P<0.05)。结论右美托咪定辅助喉罩全麻用于老年全髋关节置换手术,可以增强血流动力学的稳定性,降低术后躁动发生率。 Objective To investigate the influence of dexmedtomidine on emergence agitation(EA) undergo- ing total hip replacement surgery. Methods 60 patients undergoing total hip replacement surgery in our hospital from January 2012 to March 2013, were randomly divided into observation group and control group at 30 cases in each group. Both groups used the laryngeal mask anesthesia at 30 rain before the end of surgery. Patients in observation group were subjected to intravenous dexmedtomldine, while control group received intravenous normal saline. The he- modynamic indexes and the incidence of emergence agitationin of the two groups were recorded. Results The patients' blood pressure, heart rate and other indicators in observation group soon returned to baseline levels, while the control group recovered more slowly, and the indexes above did not return to baseline levels in control group 5 mins later. The rate of EA in observation group was 3.33% , while it was 13.33% in control group,there were significant differences between the two groups ( P 〈 0.05 ). Conclusion Dexmedetomidine auxiliary laryngeal mask anesthesia in elderly hip replacement surgery can enhance hemodynamic stability, and reduce the rate of postoperative agitation.
出处 《实用药物与临床》 CAS 2013年第11期1004-1006,共3页 Practical Pharmacy and Clinical Remedies
关键词 右美托咪定 全髋关节置换手术 苏醒期躁动 Dexmedetomidine Total hip replacement surgery Agitation during recovery
  • 相关文献

参考文献10

二级参考文献98

  • 1张曙,段思源,冯凤钜.插管型喉罩用于困难气道的临床研究[J].中国临床医学,2006,13(5):829-831. 被引量:3
  • 2田复波,黄绍强.全麻妇科腹腔镜手术喉罩通气道和气管插管的效果比较[J].中国临床医学,2007,14(1):67-69. 被引量:10
  • 3皮铎波,余静,瞿巍巍,王志云,刘君君.咪唑安定伍用曲马多于硬膜外麻醉中清醒镇静的观察[J].浙江临床医学,2007,9(8):1141-1141. 被引量:2
  • 4ANTI'ILA M, PEN3"TILA J, HELMINEN A, et al. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects [J]. Br J Clin Pharmacol,2003,56(6) :691 -693.
  • 5KAMIBAYASHI T, MAZE M. Clinical uses ofet2 -adrenergic ag- onists [ J ]. Aneasthesiology. 2000,93 (5) : 1345 - 1349.
  • 6RUOTSALAINEN S, HAAPALINNA A, RIEKKINEN PJ SR, et al. Dexmedetomidine reduces response tendency, but not accuracy of rats in attention and short -term memory tasks[ J]. Pharmacol Biochem Behav, 1997,56( 1 ) :31 -40.
  • 7AANTAA R. Assessment of the sedative effects of dexmedetomi- dine, an alpha 2 - adrenoceptor agonist, with analysis of saccadic eye movements [ J ]. Pharmacol Toxicol, 1991,68 ( 5 ) : 394 - 398.
  • 8MANTZ J. Phase Ⅲ study on dexmedetomidine used for postoper- ation sedation of patients requiring mechanical ventilation for less than 24 hours : the French experrience [ J ]. Middle East J Anes- thesiol, 2002,16(6) :597 -606.
  • 9MEERT T F, de KOCK M. Potentiation of the analgesic properties of fentanyl - like opioids with alpha2 - adrenoceptor agonists in rats[ J]. Anesthesiology, 1994,81 (3) :677 - 688.
  • 10JAAKOLA M L, SALONEN M, LEHTINEN R, et al. The analge- sic action of dexmedetomidine - a novel alpha2 - adrenoceptor ago- nist - in healthy volunteers [ J ]. Pain, 1991,46 ( 3 ) : 281 - 285.

共引文献116

同被引文献29

  • 1Cram P, Lu X, Kaboli PJ, et al. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991-2008. JAMA, 201 l, 305 ( 15 ) : 1560-1567.
  • 2Harley BJ, Beaupr$ LA, Jones CA, et al. The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study [J]. Can J Surg, 2002,45 (3) : 185-190.
  • 3Alshryda S, Sukeik M, Sarda P, et al. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement [J]. Bone Joint J, 2014,96-B (8) : 1005-1015.
  • 4Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account [J]. J Bone Joint Surg Br, 2004, 86(4) : 561-565.
  • 5Gross JB. Estimating allowable blood loss: corrected for dilution [J]. Anesthesiology, 1983,58 (3) : 277-280.
  • 6Ker K, Roberts I. Tranexamie acid for surgical bleeding [ J ]. BMJ, 2014,13,349:g4934.
  • 7Raveendran R, Wong J. Tranexamie acid: more evidence for its use in joint replacement surgery [J]. Transfusion, 2014,54( 1 ) : 2-3.
  • 8Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account [J]. J Bone Joint Surg Br, 2004,86(4) : 561-565.
  • 9Martin JG, Cassatt KB, Kincaid-Cinnamon KA, et al. Topical administration of tranexamic acid in primary total hip and total knee arthroplasty [ J ]. J Arthroplasty, 2014,29 (5) : 889 - 894.
  • 10Benoni G, Lethagen S, Nilsson P, et al. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty [J]. Acta Orthop Scand, 2000,71 (3) : 250-254.

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部